A digital cancer therapy built to support more effective care
The Mika app is a digital therapy intended to help patients reduce cancer-related distress, enable more effective care delivery, and offer life science partners data-driven treatment insights.
Contact us to learn more
Evidence-based digital intervention
Mika delivers digital psycho-oncological therapy, physical rehabilitation training, nutritional recommendations, and rigorously fact-checked, doctor-validated educational content.
Certified Class II SaMD
Mika’s digital therapeutic is a CE marked, certified medical device in accordance with Medical Device Regulation EU MDR 2017/745 Class IIa, ISO 13485, and ISO 27001 for data protection.
Developed with leading institutions
Mika is co-developed with leading oncology institutes like Charité Berlin, University Hospital Leipzig, University Hospital Düsseldorf and Germany’s top cancer treatment centers.
Optimize therapies with data-driven treatment insights
Cancer patients can lack access to reliable information, adequate emotional support, and simple training methods that boost overall wellbeing.
Mika’s digital therapeutic fills this gap and provides patients with a proactive way to drive their own self-care, track symptoms and side effects, and educate themselves about their condition.
As an addition to prescribed therapies, Mika can give patients a sense of agency and help them build the resilience they need to minimize treatment breakpoints.
Life science partners can use Mika’s data insights to shine a light on how patients experience their treatments day to day so they can optimize pharmacotherapies.
Mika helps cancer patients feel supported
Thousands of cancer patients use the Mika app to ease distress during cancer.
The right treatment for the right patient at the right time
The life science industry has a severely limited view of how real-world oncology patients respond to and experience their pharmacotherapies.
With Mika, life science teams can gain the visibility they need to optimize support and access programs as well as patient and care team education.
They can also gather insights to inform the development of new therapies and treatment regimes. Operating more effectively can help life science teams achieve the Quadruple Aim.
Healthcare professionals trust Mika
Mika’s digital therapy is loved by experts and used in Europe’s leading oncology clinics.
„Digital therapeutic support, as provided by the Mika app, represents a meaningful improvement in the care provided in oncology.“
Prof. Dr. Anja Mehnert-Teuerkauf
Department Head of Medical Psychology and Medical Sociology, Leipzig University Cancer Center
„I see the Mika cancer app as a very innovative add-on in the field of cancer patient education and information."
Prof. Dr. med. Dr. h.c. Jalid Sehouli
Director of Gynecology, Charité University Hospital
„The indispensable thing about the Mika app is that patients receive medically correct information. [...] Patients cannot get themselves 'lost' on the internet and cannot become victims of unfair business interests.“
Prof. Dr. med. Diana Lüftner
Member of the DGHO Board
Mika is Europe’s largest, most reliable oncology DTx
Partnering with Mika gives life science teams access to actionable treatment insights from Europe’s fastest-growing clinically-validated DTx (digital therapeutics) platform.
- Mika has supported more than 100,000 cancer patients since 2018
- Patients spend more than 20 minutes per week using the Mika app
- Patients spend more than 3 months using Mika during the most critical time window for therapy response, durability, and persistence
- Using Mika is clinically proven to reduce fatigue by 23% and psychological distress by 42%